Artivion Competitors

AORT Stock  USD 25.73  0.31  1.22%   
Artivion competes with Anika Therapeutics, Sight Sciences, Orthofix Medical, Avanos Medical, and Axogen; as well as few others. The company conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Artivion competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Artivion to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Artivion Correlation with its peers.
For more information on how to buy Artivion Stock please use our How to Invest in Artivion guide.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Artivion competition on your existing holdings.
  
Return On Tangible Assets is likely to gain to -0.09 in 2025. Return On Capital Employed is likely to drop to 0.01 in 2025. At this time, Artivion's Fixed Asset Turnover is comparatively stable compared to the past year. Asset Turnover is likely to gain to 0.88 in 2025, despite the fact that Return On Tangible Assets are likely to grow to (0.09).
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
23.5425.5527.56
Details
Intrinsic
Valuation
LowRealHigh
22.8830.0932.10
Details
Naive
Forecast
LowNextHigh
22.5624.5726.58
Details
6 Analysts
Consensus
LowTargetHigh
30.1833.1736.82
Details

Artivion Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Artivion and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Artivion and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Artivion does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
SRDXSGHT
CNMDSGHT
AVNSOFIX
CNMDAVNS
OFIXANIK
AVNSSGHT
  
High negative correlations   
AXGNSGHT
SRDXAXGN
CNMDLUNG
AXGNAVNS
CNMDAXGN
SRDXELMD

Risk-Adjusted Indicators

There is a big difference between Artivion Stock performing well and Artivion Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Artivion's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ANIK  1.26  0.06  0.04  0.07  1.41 
 2.82 
 6.97 
SGHT  2.65 (0.38) 0.00 (0.40) 0.00 
 6.65 
 15.53 
OFIX  1.13 (0.12) 0.00 (0.19) 0.00 
 2.18 
 6.60 
AVNS  1.53 (0.22) 0.00 (1.66) 0.00 
 3.82 
 13.49 
AXGN  2.55  0.70  0.28  1.98  2.24 
 5.32 
 21.20 
LUNG  3.19  0.76  0.26 (1.03) 2.57 
 6.22 
 34.92 
ELMD  2.56  0.03  0.01  0.02  3.06 
 5.82 
 21.31 
SRDX  0.85 (0.13) 0.00 (0.86) 0.00 
 1.67 
 9.34 
NUVA  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
CNMD  1.67 (0.21) 0.00 (0.22) 0.00 
 3.50 
 13.79 

Cross Equities Net Income Analysis

Compare Artivion and related stocks such as Anika Therapeutics, Sight Sciences, and Orthofix Medical Net Income Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioFree Cash Flow Yield
Operating Cash Flow Per ShareStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Free Cash Flow Per ShareRoic
Inventory TurnoverNet Income Per Share
Payables TurnoverSales General And Administrative To Revenue
Research And Ddevelopement To RevenueCapex To Revenue
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioIncome Quality
RoePe Ratio
Return On Tangible AssetsEarnings Yield
Intangibles To Total AssetsCurrent Ratio
Receivables TurnoverDebt To Equity
Capex Per ShareRevenue Per Share
Debt To AssetsDays Sales Outstanding
Book Value Per ShareInvested Capital
Average PayablesEv To Sales
Days Of Inventory On HandAverage Inventory
Cash Per ShareDays Payables Outstanding
Net Current Asset ValueTangible Asset Value
Ev To Operating Cash FlowEv To Free Cash Flow
Net Debt To E B I T D ATangible Book Value Per Share
Graham NumberShareholders Equity Per Share
Graham Net NetAverage Receivables
Interest Debt Per ShareEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioOperating Cash Flow Sales Ratio
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityOperating Cycle
Days Of Payables OutstandingCash Conversion Cycle
Days Of Inventory OutstandingDays Of Sales Outstanding
Enterprise Value Multiple
2010201120122013201420152016201720182019202020212022202320242025
ANIK(1.6 M)8.5 M11.8 M20.6 M38.3 M30.8 M32.5 M31.8 M18.7 M27.2 M(24 M)4.1 M(14.9 M)(82.7 M)(95.1 M)(90.3 M)
SGHT(14.3 M)(14.3 M)(14.3 M)(14.3 M)(14.3 M)(14.3 M)(14.3 M)(14.3 M)(14.3 M)(25.9 M)(34.7 M)(63 M)(86.2 M)(55.5 M)(50 M)(52.5 M)
OFIXM(1.1 M)51.3 M(28.5 M)(8.5 M)(2.8 M)3.1 M6.2 M13.8 M(28.5 M)2.5 M(38.4 M)(19.7 M)(151.4 M)(123.9 M)(117.7 M)
AVNS142.4 M142.4 M152.6 M154.6 M27.1 M(426.3 M)39.8 M79.3 M57.5 M(45.9 M)(27.2 M)6.3 M50.5 M(61.8 M)(55.6 M)(52.8 M)
AXGN500 K(9.2 M)(9.4 M)(14.6 M)(17.7 M)(13.4 M)(14.4 M)(10.4 M)(22.4 M)(29.1 M)(24.8 M)(28.1 M)(27.3 M)(21.7 M)(10 M)(10.5 M)
LUNG(1.2 M)(1.2 M)(1.2 M)(1.2 M)(1.9 M)(2.8 M)(2.8 M)(5.4 M)(18.5 M)(20.7 M)(32.2 M)(48.7 M)(58.9 M)(60.8 M)(56.4 M)(53.6 M)
ELMD267.9 K186.6 K(1.3 M)(1.3 M)1.1 M2.2 M2.2 M1.9 MM4.2 M2.4 M2.3 M3.2 M5.2 M5.9 M6.2 M
SRDX1.6 M10.2 M15.2 M12 M13.4 M10 M3.9 M(4.5 M)7.6 M1.1 M4.2 M(27.3 M)(1.5 M)(11.5 M)(10.4 M)(9.9 M)
CNMD700 K752 K40.5 M35.9 M32.2 M30.5 M14.7 M55.5 M40.9 M28.6 M9.5 M62.5 M(80.6 M)64.5 M132.4 M139 M
KIDS(9.5 M)(9.5 M)(9.5 M)(9.5 M)(9.5 M)(7.9 M)(6.6 M)(8.9 M)(12 M)(17.2 M)(32.9 M)(16.3 M)1.3 M(21 M)(18.9 M)(19.8 M)
SIBN(10.9 M)(10.9 M)(10.9 M)(6.2 M)(27.8 M)(28.2 M)(20.6 M)(23 M)(17.5 M)(42.6 M)(48.5 M)(60.1 M)(62.9 M)(43.3 M)(30.9 M)(32.5 M)
NPCE(40.7 M)(40.7 M)(40.7 M)(40.7 M)(40.7 M)(40.7 M)(40.7 M)(40.7 M)(40.7 M)(40.7 M)(36 M)(38.1 M)(53.4 M)(33 M)(29.7 M)(31.1 M)
CVRX(14.6 M)(14.6 M)(14.6 M)(14.6 M)(14.6 M)(14.6 M)(14.6 M)(14.6 M)(14.6 M)(14.6 M)(14.1 M)(43.1 M)(41.4 M)(41.2 M)(60 M)(57 M)
ITGR(2.3 M)33.1 M(4.8 M)36.3 M55.5 M(7.6 M)M66.7 M168 M96.3 M77.3 M96.8 M66.4 M90.7 M119.9 M125.9 M
TMCI(5.1 M)(5.1 M)(5.1 M)(5.1 M)(5.1 M)(5.1 M)(5.1 M)(5.1 M)(5.1 M)(5.1 M)(6.4 M)(24.6 M)(47.3 M)(49.5 M)(44.6 M)(42.3 M)
ESTA(1.6 M)(1.6 M)(1.6 M)(1.6 M)(1.6 M)(1.6 M)(22.2 M)(34.9 M)(21.1 M)(38.1 M)(38.1 M)(41.1 M)(75.2 M)(78.5 M)(70.7 M)(67.1 M)
JavaScript chart by amCharts 3.21.15Macroaxis Charts2012201420162018202020222024 10100
JavaScript chart by amCharts 3.21.15Anika Therapeuticstotal: 70.4Sight Sciencestotal: 1.4KOrthofix Medicaltotal: 25.75Avanos Medicaltotal: 28.26Axogen Inctotal: 82.15Pulmonx Corptotal: 527.27Electromedtotal: 27.73SurModicstotal: 90.54CONMEDtotal: 31.79Orthopediatrics Corptotal: 101.65Si Bonetotal: 82.5Neuropacetotal: 199.39CVRx Inctotal: 90.02Integer Holdings Corptotal: 30.94Treace Medical Conceptstotal: 387.28Establishment Labs Holdingstotal: 232.66

Artivion and related stocks such as Anika Therapeutics, Sight Sciences, and Orthofix Medical Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Artivion financial statement analysis. It represents the amount of money remaining after all of Artivion operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Artivion Competitive Analysis

The better you understand Artivion competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Artivion's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Artivion's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
AORT ANIK SGHT OFIX AVNS AXGN LUNG ELMD SRDX CNMD
 1.22 
 25.73 
Artivion
 0.68 
 17.57 
Anika
 5.34 
 2.66 
Sight
 0.58 
 17.36 
Orthofix
 0.45 
 15.56 
Avanos
 1.28 
 19.21 
Axogen
 6.07 
 8.66 
Pulmonx
 0.40 
 27.57 
Electromed
 1.31 
 35.43 
SurModics
 2.47 
 59.90 
CONMED
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Five Year Return
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Z Score
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Last Dividend Paid
Shares Owned By Institutions
Market Capitalization
Price To Earnings To Growth
Price To Earning
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Relative Strength Index
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Artivion Competition Performance Charts

JavaScript chart by amCharts 3.21.15Dec2025FebJan 16Jan 21Jan 26Jan 31FebFeb 10Feb 15Feb 20Feb 25-20%-10%0%10%20%30% Show all
JavaScript chart by amCharts 3.21.15Artivion Anika Therapeutics Sight Sciences Orthofix Medical Avanos Medical Axogen Inc Pulmonx Corp Electromed SurModics Dow Jones Industrial

Five steps to successful analysis of Artivion Competition

Artivion's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Artivion in relation to its competition. Artivion's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Artivion in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Artivion's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Artivion, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Artivion position

In addition to having Artivion in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Beers Thematic Idea Now

Beers
Beers Theme
Companies involved in production and distribution of domestic and international beer. The Beers theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Beers Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Artivion Stock Analysis

When running Artivion's price analysis, check to measure Artivion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Artivion is operating at the current time. Most of Artivion's value examination focuses on studying past and present price action to predict the probability of Artivion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Artivion's price. Additionally, you may evaluate how the addition of Artivion to your portfolios can decrease your overall portfolio volatility.